$57.75
0.310.54%
At close: -
$56.89
-0.86-1.49%
After Hours: 6:32 PM EDT
Comments
Loading...
Halozyme Therapeutics (NASDAQ:HALO) Stock, Earnings Estimates, EPS, And Revenue
Halozyme Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$1.080
Quarterly Revenue Estimate
$263.72M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.02B
Analyze the earnings history of Halozyme Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Halozyme Therapeutics (HALO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-18 | $1.26 | $1.16 | 8.62 % |
| Q3 | 2024-10-31 | $1.27 | $0.98 | 29.6 % |
| Q2 | 2024-08-06 | $0.91 | $0.78 | 16.7 % |
| Q1 | 2024-05-07 | $0.79 | $0.69 | 14.5 % |
Halozyme Therapeutics (HALO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-18 | $298.01M | $285.74M | 4.29 % |
| Q3 | 2024-10-31 | $290.08M | $251.06M | 15.5 % |
| Q2 | 2024-08-06 | $231.35M | $208.94M | 10.7 % |
| Q1 | 2024-05-07 | $195.88M | $199.78M | -1.95 % |
FAQ
When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?
Halozyme Therapeutics (HALO) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 18, 2025 for Q4.
What were the latest earnings per share (EPS) for Halozyme Therapeutics (NASDAQ:HALO)?
The Actual EPS was $1.26, which beat the estimate of $1.16.
What were Halozyme Therapeutics’s (NASDAQ:HALO) revenues?
The Actual Revenue was $298M, which beat the estimate of $285.7M.
Browse earnings estimates, EPS, and revenue on all stocks.